Home  >  News
Msc_Apr23 .
you can get e-magazine links on WhatsApp. Click here
  UKHSA announces new UK-based vaccine deal to boost pandemic preparedness against influenza,   September 28, 2023
  GSK’s Arexvy receives Japanese regulatory approval for prevention of respiratory syncytial virus disease for older adults,   September 26, 2023
  Pfizer broadens portfolio of respiratory vaccines recommended by US CDC advisory committee with Abrysvo for RSV,   September 25, 2023
  Phylex BioSciences announces Nipah virus vaccine initiative with its nanoparticle mRNA vaccine technology,   September 25, 2023
  Aditum Bio forms Celexor Bio, focused on cell depletion of pathologic cells in autoimmune and inflammatory disorders,   September 23, 2023
  Novo Nordisk Foundation to invest €127 million to establish world-class cell therapy facility,   September 22, 2023
  BSV hosts groundbreaking ceremony for new bio-pharmaceutical manufacturing plant in Genome Valley, Telangana,   September 21, 2023
  Biocon Biologics gets European marketing approval for Yesafili, biosimilar aflibercept,   September 20, 2023
  CordenPharma increases peptide production capacity to meet growing market demand,   September 16, 2023
  NEC selected by Japan AMED for design of universal vaccine that is effective against influenza virus strains,   September 15, 2023
  GSK, Save the Children renew award-winning partnership, with focus on ‘zero dose’ children who have never received a vaccine,   September 15, 2023
  Clover introduces AdimFlu-S (QIS), a quadrivalent seasonal influenza vaccine in mainland China,   September 13, 2023
  Evaxion achieves milestone in vaccine discovery with validation of its AI-powered vaccine discovery platform, Eden,   September 13, 2023
  Pfizer, BioNTech receive US FDA approval for 2023-2024 Covid-19 vaccine,   September 13, 2023
  Merck’s Ervebo gets European Commission’s expanded indication approval for active immunization of individuals 1 year of age or older to protect against EVD,   September 08, 2023
  UK MHRA approves Pfizer/BioNTech’s adapted Covid-19 vaccine (Comirnaty) that targets Omicron XBB.1.5,   September 07, 2023
  Biocon Biologics expands global footprint, completes integration of Viatris biosimilars’ business in North America,   September 06, 2023
  Biogenysis partners with Khalpey AI Lab & Contenta to identify biomarkers for early onset Alzheimer's disease,   September 06, 2023
  ERS Genomics & AlgenScribe enter into CRISPR/Cas9 licensing agreement,   September 06, 2023
  Pfizer, BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted Covid-19 vaccine in European Union,   August 31, 2023

Pharma live expo
Copyright © 2023 Saffron Media Pvt. Ltd |